This paper is critical of the conduct of some clinical trials in Myanmar. The abstract is below. The full paper is attached or you can email him for a copy. It is on the web at http://www.globalizationandhealth.com/content/3/1/10

[him] moderator

******************************

Health, human rights, and the conduct of clinical research within oppressed populations

Abstract:

Background:    Clinical  trials  evaluating  interventions  for  infectious  diseases  require  enrolling
participants  that  are  vulnerable  to  infection.    As  clinical  trials  are  conducted  in  increasingly
vulnerable populations, issues of protection of these populations become challenging. In settings
where populations are forseeably oppressed, the conduct of research requires considerations that
go beyond common ethical concerns and into issues of international human rights law.

Discussion: Using examples of HIV prevention trials in Thailand, hepatitis-E prevention trials in
Nepal and malaria therapeutic trials in Burma (Myanmar), we address the inadequacies of current
ethical guidelines when conducting  research within oppressed populations.   We  review existing
legislature  in  the  United  States  and  United  Kingdom  that  may  be  used  against  foreign
investigators  if  trial  hardships  exist.    We  conclude  by  making  considerations  for  research
conducted within oppressed populations.